These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33994494)

  • 1. Combining the Tumor Contact Length and Apparent Diffusion Coefficient Better Predicts Extraprostatic Extension of Prostate Cancer with Capsular Abutment: A 3 Tesla MR Imaging Study.
    Ito K; Chiba E; Oyama-Manabe N; Washino S; Manabe O; Miyagawa T; Hamamoto K; Hiruta M; Tanno K; Shinmoto H
    Magn Reson Med Sci; 2022 Jul; 21(3):477-484. PubMed ID: 33994494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the most optimal multiparametric magnetic resonance imaging sequence for determining pathological length of capsular contact.
    Onay A; Vural M; Armutlu A; Ozel Yıldız S; Kiremit MC; Esen T; Bakır B
    Eur J Radiol; 2019 Mar; 112():192-199. PubMed ID: 30777210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Length of capsular contact for diagnosing extraprostatic extension on prostate MRI: Assessment at an optimal threshold.
    Rosenkrantz AB; Shanbhogue AK; Wang A; Kong MX; Babb JS; Taneja SS
    J Magn Reson Imaging; 2016 Apr; 43(4):990-7. PubMed ID: 26395278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of MRI for diagnosis of extraprostatic extension in prostate cancer.
    Krishna S; Lim CS; McInnes MDF; Flood TA; Shabana WM; Lim RS; Schieda N
    J Magn Reson Imaging; 2018 Jan; 47(1):176-185. PubMed ID: 28387981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of apparent diffusion coefficient and MR volumetry as independent associative factors for extra-prostatic extension (EPE) in prostatic carcinoma.
    Lim C; Flood TA; Hakim SW; Shabana WM; Quon JS; El-Khodary M; Thornhill RE; El Hallani S; Schieda N
    J Magn Reson Imaging; 2016 Mar; 43(3):726-36. PubMed ID: 26303719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study evaluating indirect MRI-signs for the prediction of extraprostatic disease in patients with prostate cancer: tumor volume, tumor contact length and tumor apparent diffusion coefficient.
    Rud E; Diep L; Baco E
    World J Urol; 2018 Apr; 36(4):629-637. PubMed ID: 29349572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative MRI in the Local Staging of Prostate Cancer: A Systematic Review and Meta-Analysis.
    Xiao VG; Kresnanto J; Moses DA; Pather N
    J Magn Reson Imaging; 2024 Jan; 59(1):255-296. PubMed ID: 37165923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between amount of extra-prostatic extension and length of capsular contact: performances from MR images and radical prostatectomy specimens.
    Onay A; Bakır B
    Turk J Med Sci; 2021 Aug; 51(4):1940-1952. PubMed ID: 33862674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which one is better for predicting extraprostatic extension on multiparametric MRI: ESUR score, Likert scale, tumor contact length, or EPE grade?
    Asfuroğlu U; Asfuroğlu BB; Özer H; Gönül İI; Tokgöz N; İnan MA; Uçar M
    Eur J Radiol; 2022 Apr; 149():110228. PubMed ID: 35255320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can Extraprostatic Extension Be Predicted by Tumor-Capsule Contact Length in Prostate Cancer? Relationship With International Society of Urological Pathology Grade Groups.
    Bakir B; Onay A; Vural M; Armutlu A; Yıldız SÖ; Esen T
    AJR Am J Roentgenol; 2020 Mar; 214(3):588-596. PubMed ID: 31670596
    [No Abstract]   [Full Text] [Related]  

  • 11. Prediction of extraprostatic extension by MRI tumor contact length: difference between anterior and posterior prostate cancer.
    Matsumoto K; Akita H; Narita K; Hashiguchi A; Takamatsu K; Takeda T; Kosaka T; Mizuno R; Kikuchi E; Oya M; Jinzaki M
    Prostate Cancer Prostatic Dis; 2019 Dec; 22(4):539-545. PubMed ID: 30814680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor contact with prostate capsule on magnetic resonance imaging: A potential biomarker for staging and prognosis.
    Kongnyuy M; Sidana A; George AK; Muthigi A; Iyer A; Ho R; Chelluri R; Mertan F; Frye TP; Su D; Merino MJ; Choyke PL; Wood BJ; Pinto PA; Turkbey B
    Urol Oncol; 2017 Jan; 35(1):30.e1-30.e8. PubMed ID: 27567248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extra-prostatic extension grading system: correlation with MRI features and integration of capsular enhancement sign for "enhanced" detection of T3a lesions.
    Martini F; Pigati M; Mattiauda M; Ponzano M; Piol N; Pigozzi S; Spina B; Cittadini G; Giasotto V; Zawaideh JP
    Br J Radiol; 2024 May; 97(1157):971-979. PubMed ID: 38544291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR-based simplified extraprostatic extension evaluation: comparison of performances of different predictive models.
    Schirò S; Milanese G; Maddalo M; Ziglioli F; Maestroni UV; Manna C; Ledda RE; Negrini G; Mastrapasqua F; Cobelli R; Tamburino G; Conti ME; Luceri S; Leo L; Ghetti C; Sverzellati N
    Eur Radiol; 2023 Apr; 33(4):2975-2984. PubMed ID: 36512046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer: utility of diffusion-weighted imaging as a marker of side-specific risk of extracapsular extension.
    Rosenkrantz AB; Chandarana H; Gilet A; Deng FM; Babb JS; Melamed J; Taneja SS
    J Magn Reson Imaging; 2013 Aug; 38(2):312-9. PubMed ID: 23238968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of observation size and apparent diffusion coefficient (ADC) value in PI-RADS v2.1 assessment category 4 and 5 observations compared to adverse pathological outcomes.
    Abreu-Gomez J; Walker D; Alotaibi T; McInnes MDF; Flood TA; Schieda N
    Eur Radiol; 2020 Aug; 30(8):4251-4261. PubMed ID: 32211965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extraprostatic extension in multiparametric MRI; Is presurgical detection possible?
    Ayaz M; Gülseren Y; İnan İ; Ok F; Kabaalioğlu A; Yıldırım A
    J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S639-S644. PubMed ID: 38384032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detectability of low and intermediate or high risk prostate cancer with combined T2-weighted and diffusion-weighted MRI.
    Doo KW; Sung DJ; Park BJ; Kim MJ; Cho SB; Oh YW; Ko YH; Yang KS
    Eur Radiol; 2012 Aug; 22(8):1812-9. PubMed ID: 22466514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of extraprostatic extension on multi-parametric magnetic resonance imaging in patients with anterior prostate cancer.
    Ahn H; Hwang SI; Lee HJ; Suh HS; Choe G; Byun SS; Hong SK; Lee S; Lee J
    Eur Radiol; 2020 Jan; 30(1):26-37. PubMed ID: 31385046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness.
    Vargas HA; Akin O; Franiel T; Mazaheri Y; Zheng J; Moskowitz C; Udo K; Eastham J; Hricak H
    Radiology; 2011 Jun; 259(3):775-84. PubMed ID: 21436085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.